4,864 Stryker Corporation $SYK Shares Purchased by Nisa Investment Advisors LLC

Nisa Investment Advisors LLC raised its stake in Stryker Corporation (NYSE:SYK) by 5.1% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 100,808 shares of the medical technology company’s stock after buying an additional 4,864 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Stryker were worth $27,850,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Gables Capital Management Inc. acquired a new stake in shares of Stryker during the 2nd quarter valued at $25,000. Kilter Group LLC purchased a new position in shares of Stryker during the 2nd quarter valued at $25,000. Highland Investment Advisors LLC purchased a new position in shares of Stryker during the 2nd quarter valued at $25,000. Cornerstone Financial Management LLC increased its stake in shares of Stryker by 66.0% in the second quarter. Cornerstone Financial Management LLC now owns 78 shares of the medical technology company’s stock worth $25,000 after acquiring an additional 31 shares during the last quarter. Finally, Compass Financial Management LLC acquired a new position in shares of Stryker in the second quarter worth $27,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on SYK shares. UBS Group assumed coverage on Stryker in a report on Tuesday, July 28th. They set a “buy” rating and a $400.00 price objective for the company. BTIG Research lowered their target price on Stryker from $358.00 to $316.00 and set a “buy” rating on the stock in a research note on Monday, October 12th. Citizens Jmp lowered their target price on Stryker from $440.00 to $400.00 and set a “market outperform” rating on the stock in a research note on Monday, August 3rd. Royal Bank Of Canada dropped their target price on Stryker from $435.00 to $420.00 and set an “outperform” rating on the stock in a research report on Friday, July 31st. Finally, Canaccord Genuity Group cut their price target on Stryker from $400.00 to $385.00 and set a “buy” rating for the company in a research note on Friday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, Stryker has an average rating of “Moderate Buy” and a consensus price target of $369.00.

Insider Buying and Selling

In other Stryker news, insider Debra King sold 826 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider directly owned 6,210 shares in the company, valued at $2,088,423. This trade represents a 11.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Dylan Crotty sold 441 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the transaction, the insider owned 6,102 shares in the company, valued at approximately $2,005,178.22. This trade represents a 6.74% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 351,267 shares of company stock worth $118,197,701. Corporate insiders own 4.60% of the company’s stock.

Stryker Price Performance

NYSE SYK opened at $304.59 on Wednesday. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $116.83 billion, a PE ratio of 31.56, a price-to-earnings-growth ratio of 1.92 and a beta of 0.78. The company has a 50 day moving average price of $297.53 and a two-hundred day moving average price of $312.37. Stryker Corporation has a 12-month low of $267.00 and a 12-month high of $392.55.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The company had revenue of $6.59 billion during the quarter, compared to the consensus estimate of $6.58 billion. During the same period in the previous year, the firm posted $3.13 earnings per share. The company’s revenue for the quarter was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities analysts predict that Stryker Corporation will post 14.93 earnings per share for the current fiscal year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be paid a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.2%. The ex-dividend date of this dividend is Wednesday, September 30th. Stryker’s payout ratio is presently 36.48%.

About Stryker

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.